Patents by Inventor Roger D. Kornberg

Roger D. Kornberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12111313
    Abstract: A field effect transistor comprising a chelator or derivatized chelator, a device for detecting a marker in a sample comprising said sensor, a method for detecting metal ions in a sample comprising said sensor or device and a sensor and method for detecting a marker in a sample.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: October 8, 2024
    Assignee: Autonomous Medical Devices Inc.
    Inventor: Roger D. Kornberg
  • Patent number: 11732381
    Abstract: Embodiments herein describe systems and methods to identify transcription factor activation domains and uses thereof. Many embodiments obtain activation measurements of tiles or segments of known transcription factors in an organism. Further embodiments train a machine learning model, such as a convolutional neural network, to identify transcription factors and activation domains in other organisms of the same or different species. Such methods and systems can be used for industrial, medical, and research purposes.
    Type: Grant
    Filed: December 15, 2021
    Date of Patent: August 22, 2023
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Roger D. Kornberg, Adrian Sanborn, Benjamin Yeh
  • Publication number: 20220186401
    Abstract: Embodiments herein describe systems and methods to identify transcription factor activation domains and uses thereof. Many embodiments obtain activation measurements of tiles or segments of known transcription factors in an organism. Further embodiments train a machine learning model, such as a convolutional neural network, to identify transcription factors and activation domains in other organisms of the same or different species. Such methods and systems can be used for industrial, medical, and research purposes.
    Type: Application
    Filed: December 15, 2021
    Publication date: June 16, 2022
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Roger D. Kornberg, Adrian Sanborn, Benjamin Yeh
  • Publication number: 20210310044
    Abstract: The disclosure relates to antibody conjugates comprising an antibody linked to a polynucleotide, aptamer conjugates comprising an aptamer linked to a polynucleotide, and methods for detecting a marker or several markers in a sample by using said antibody and aptamer conjugates. The present disclosure also relates to microfluidics devices for detecting markers in a sample. The present disclosure further relates to methods for detecting a microorganism or several microorganisms in a sample and a microfluidics device to be used to detect such microorganisms.
    Type: Application
    Filed: October 12, 2019
    Publication date: October 7, 2021
    Applicant: Autonomous Medical Devices Inc.
    Inventor: Roger D. Kornberg
  • Publication number: 20210311028
    Abstract: The disclosure relates to antibody conjugates or aptamer conjugates comprising an antibody linked to a lipid vesicle comprising a detectable label, methods for detecting a marker or several markers in a sample by using said antibody and aptamer conjugates. The present disclosure further relates to microfluidics devices to detect one or more markers in a sample by using said antibody and aptamer conjugates.
    Type: Application
    Filed: October 11, 2019
    Publication date: October 7, 2021
    Applicant: Autonomous Medical Devices Inc.
    Inventor: Roger D. Kornberg
  • Publication number: 20210293798
    Abstract: The disclosure relates to a Field Effect Transistor comprising a chelator or derivatized chelator, a device for detecting a marker in a sample comprising said sensor, a method for detecting metal ions in a sample comprising said sensor or device and a sensor and method for detecting a marker in a sample.
    Type: Application
    Filed: August 14, 2019
    Publication date: September 23, 2021
    Applicant: Autonomous Medical Devices Inc.
    Inventor: Roger D. Kornberg
  • Publication number: 20170304902
    Abstract: Methods of synthesizing water-soluble thiolate-protected gold nanoparticles of uniform size and conjugates thereof are disclosed. In particular, the invention relates to a method of synthesizing homogeneous, water-soluble gold nanoparticles by using a modified Brust procedure and methods of conjugating them. Gold nanoparticles, produced by the methods of the invention, are useful in various therapeutic and imaging applications where the use of gold nanoparticles having uniform structural and optical properties is desired.
    Type: Application
    Filed: April 21, 2017
    Publication date: October 26, 2017
    Inventors: Maia Azubel, Roger D. Kornberg
  • Patent number: 8304257
    Abstract: Improved methods for preparing thiolate passivated gold nanoparticles are provided resulting in a narrower size distribution. By alternating oxidation and reduction of the particles, after oxidation, the thiolates may be readily displaced with a different thiol, followed by reduction to prevent further reaction. Proteins can be rigidly bound to the gold nanoparticles by binding an scFv for a target protein to the gold nanoparticles, where the scFv prior or subsequent to binding to the gold nanoparticles may be complexed with the target protein. The protein is rigidly held and its structure readily determined using electron microscopy.
    Type: Grant
    Filed: March 8, 2007
    Date of Patent: November 6, 2012
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Christopher J. Ackerson, Pablo Jadzinsky, Roger D. Kornberg
  • Publication number: 20080195324
    Abstract: Crystals and structures are provided for an eukaryotic RNA polymerase, and an elongation complex containing a eukaryotic RNA polymerase. The structures and structural coordinates are useful in structural homology deduction, in developing and screening agents that affect the activity of eukaryotic RNA polymerase, and in designing modified forms of eukaryotic RNA polymerase. The structure information may be provided in a computer readable form, e.g. as a database of atomic coordinates, or as a three-dimensional model. The structures are useful, for example, in modeling interactions of the enzyme with DNA, RNA, transcription factors, nucleotides, etc. The structures are also used to identify molecules that bind to or otherwise interact with structural elements in the polymerase.
    Type: Application
    Filed: December 3, 2007
    Publication date: August 14, 2008
    Inventors: David A. Bushnell, Roger D. Kornberg, Patrick Cramer
  • Publication number: 20030232369
    Abstract: Crystals and structures are provided for an eukaryotic RNA polymerase, and an elongation complex containing a eukaryotic RNA polymerase. The structures and structural coordinates are useful in structural homology deduction, in developing and screening agents that affect the activity of eukaryotic RNA polymerase, and in designing modified forms of eukaryotic RNA polymerase. The structure information may be provided in a computer readable form, e.g. as a database of atomic coordinates, or as a three-dimensional model. The structures are useful, for example, in modeling interactions of the enzyme with DNA, RNA, transcription factors, nucleotides, etc. The structures are also used to identify molecules that bind to or otherwise interact with structural elements in the polymerase.
    Type: Application
    Filed: April 17, 2003
    Publication date: December 18, 2003
    Inventors: David A. Bushnell, Roger D. Kornberg, Patrick Cramer
  • Patent number: 4489133
    Abstract: Methods and compositions involving two-dimensional ordering of organic polar solvent soluble organic macromolecules. Lipid monolayer forming molecules are bound covalently or non-covalently to organic macromolecules soluble in polar solvents, whereby the macromolecules are allowed to become oriented in two-dimensions to form an ordered, low free energy, including crystalline, layer of macromolecules. The macromolecules may then be further combined with other moieties to create additional layers, to be cross-linked or otherwise modified, and/or separated from the lipid monolayer. The resulting ordered layers can be used for a variety of purposes, in crystallographic techniques for structure determination and structural relationship determinations, in optics, as polymers, films, and the like.
    Type: Grant
    Filed: November 16, 1982
    Date of Patent: December 18, 1984
    Assignee: The Board of Trustees of the Leland Stanford Jr. University
    Inventor: Roger D. Kornberg